Fulvestrant does not stimulate endometrial growth in postmenopausal breast cancer patients

被引：0
|
作者：
Morales, L. [1 ]
Neven, P. [1 ]
Timmerman, D. [1 ]
Wildiers, H. [1 ]
Konstantinovic, M. L. [1 ]
Tan, P. N. [1 ]
Christiaens, M-R [1 ]
Paridaens, R. [1 ]
机构：
[1] Univ Hosp KU Leuven, Fac Med, Louvain, Belgium
来源：
BREAST CANCER RESEARCH AND TREATMENT | 2007年 / 106卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S116 / S116
页数：1
相关论文
共 50 条
  • [21] Endometrial pathology of 104 postmenopausal breast cancer patients treated with tamoxifen
    Özsener, S
    Özsaran, A
    Itil, I
    Dikmen, Y
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 1998, 19 (06) : 580 - 583
  • [22] ENDOMETRIAL CHANGES IN POSTMENOPAUSAL BREAST-CANCER PATIENTS RECEIVING TAMOXIFEN
    LAHTI, E
    BLANCO, G
    KAUPPILA, A
    APAJASARKKINEN, M
    TASKINEN, PJ
    LAATIKAINEN, T
    OBSTETRICS AND GYNECOLOGY, 1993, 81 (05): : 660 - 664
  • [23] CONTINUOUS TAMOXIFEN TREATMENT IN ASYMPTOMATIC, POSTMENOPAUSAL BREAST-CANCER PATIENTS DOES NOT CAUSE AGGRAVATION OF ENDOMETRIAL PATHOLOGIES
    COHEN, I
    TEPPER, R
    ROSEN, DJD
    SHAPIRA, J
    CORDOBA, M
    DROR, Y
    ALTARAS, M
    BEYTH, Y
    GYNECOLOGIC ONCOLOGY, 1994, 55 (01) : 138 - 143
  • [24] The body mass index (BMI) and the effectiveness of the fulvestrant as treatment postmenopausal metastatic breast cancer patients
    Jagiello-Gruszfeld, A.
    Lemanska, I.
    Gorniak, A.
    Kunkiel, M.
    Glinka, E.
    Majstrak-Hulewska, A.
    Konieczna, A.
    Niwinska, A.
    Nowecki, Z.
    BREAST, 2019, 44 : S66 - S66
  • [25] Nursing Perspectives on Fulvestrant for the Treatment of Postmenopausal Women With Metastatic Breast Cancer
    Litsas, Georgia
    CLINICAL JOURNAL OF ONCOLOGY NURSING, 2011, 15 (06) : 674 - 681
  • [26] Fulvestrant for the treatment of advanced breast cancer in postmenopausal women: A Japanese study
    Watanabe, T
    Sano, M
    Ohno, S
    Inaji, H
    Nishimura, R
    Shin, E
    Nomura, Y
    Morris, C
    ANTICANCER RESEARCH, 2004, 24 (2C) : 1275 - 1280
  • [27] Case studies of fulvestrant ('Faslodex') in postmenopausal women with advanced breast cancer
    Abram, P
    Maass, N
    Rea, D
    Simon, SD
    Steger, GG
    CANCER TREATMENT REVIEWS, 2005, 31 : S17 - S25
  • [28] The role of fulvestrant in endometrial cancer
    Bogliolo, Stefano
    Cassani, Chiara
    Dominoni, Mattia
    Orlandini, Anna
    Ferrero, Simone
    Iacobone, Anna Daniela
    Viazzo, Franco
    Venturini, Pier Luigi
    Spinillo, Arsenio
    Gardella, Barbara
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2017, 13 (05) : 537 - 544
  • [29] Fulvestrant for the treatment of endometrial cancer
    Battista, Marco Johannes
    Schmidt, Marcus
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2016, 25 (04) : 475 - 483
  • [30] Endometrial cancer risk in postmenopausal breast cancer patients treated with tamoxifen or aromatase inhibitors
    Sestak, Ivana
    Cuzick, Jack
    EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM, 2016, 11 (05) : 425 - 432
12345